ACMT Position Statement: Addressing Pediatric Cannabis Exposure

被引：11
|
作者：
Amirshahi, Maryann Mazer [1 ]
Moss, Michael J. [2 ]
Smith, Silas W. [3 ]
Nelson, Lewis S. [4 ]
Stolbach, Andrew I. [5 ]
机构：
[1] Georgetown Univ, Sch Med, MedStar Washington Hosp Ctr, Dept Emergency Med, Washington, DC USA
[2] Univ Utah, Coll Pharm, Utah Poison Control Ctr, Salt Lake City, UT 84112 USA
[3] NYU, Sch Med, New York, NY USA
[4] Rutgers New Jersey Med Sch, Newark, NJ USA
[5] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
来源：
JOURNAL OF MEDICAL TOXICOLOGY | 2019年 / 15卷 / 03期
关键词：
CHILDREN; MARIJUANA;
D O I：
10.1007/s13181-019-00708-z
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
引用
收藏
页码：212 / 214
页数：3
相关论文
共 50 条
  • [41] ACMT Position Statement: Position on the Recent Judicial Challenge of US Food and Drug Administration Approval of Mifepristone
    Mazer-Amirshahi, Maryann
    Stolbach, Andrew I. I.
    Ye, Peggy
    JOURNAL OF MEDICAL TOXICOLOGY, 2023, 19 (04) : 414 - 415
  • [42] ACMT Position Statement: Role of the Medical Toxicologist in the Management of Patients with Substance Use Disorder
    Andrew I. Stolbach
    Maryann Mazer-Amirshahi
    John Cienki
    Leslie R. Dye
    Lewis S. Nelson
    Ryan Marino
    Stephanie T. Weiss
    Brandon J. Warrick
    Paul M. Wax
    Journal of Medical Toxicology, 2023, 19 : 411 - 413
  • [43] ACMT Position Statement: Allow Optimal Treatment for Healthcare Professionals with Opioid Use Disorder
    Marino, Ryan T.
    Spyres, Meghan
    Wiegand, Timothy J.
    Babu, Kavita M.
    Stolbach, Andrew
    JOURNAL OF MEDICAL TOXICOLOGY, 2022, 18 (01) : 71 - 73
  • [44] ACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use Disorder
    Ryan Marino
    Jeanmarie Perrone
    Lewis S. Nelson
    Timothy J. Wiegand
    Evan S. Schwarz
    Paul M. Wax
    Andrew I. Stolbach
    Journal of Medical Toxicology, 2019, 15 : 307 - 309
  • [45] ACMT Position Statement: Role of the Medical Toxicologist in the Management of Patients with Substance Use Disorder
    Stolbach, Andrew I. I.
    Mazer-Amirshahi, Maryann
    Cienki, John
    Dye, Leslie R. R.
    Nelson, Lewis S. S.
    Marino, Ryan
    Weiss, Stephanie T. T.
    Warrick, Brandon J. J.
    Wax, Paul M. M.
    JOURNAL OF MEDICAL TOXICOLOGY, 2023, 19 (04) : 411 - 413
  • [46] ACMT Position Statement: Medication Administration and Safety During the Response to COVID-19 Pandemic
    Brenna M. Farmer
    Jon B. Cole
    Travis D. Olives
    Natalija M. Farrell
    Rama Rao
    Lewis S. Nelson
    Maryann Mazer-Amirshahi
    Andrew I. Stolbach
    Journal of Medical Toxicology, 2020, 16 : 481 - 483
  • [47] ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic
    Andrew I. Stolbach
    Maryann Mazer-Amirshahi
    Ryan Marino
    Lewis S. Nelson
    Jeremy Sugarman
    Journal of Medical Toxicology, 2020, 16 : 342 - 345
  • [48] ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic
    Stolbach, Andrew, I
    Mazer-Amirshahi, Maryann
    Marino, Ryan
    Nelson, Lewis S.
    Sugarman, Jeremy
    JOURNAL OF MEDICAL TOXICOLOGY, 2020, 16 (03) : 342 - 345
  • [49] ACMT Position Statement: Caring for Patients with Opioid Use Disorder during Coronavirus Disease Pandemic
    Stolbach, Andrew
    Mazer-Amirshahi, Maryann
    Schwarz, Evan S.
    Juurlink, David
    Wiegand, Timothy J.
    Nelson, Lewis S.
    JOURNAL OF MEDICAL TOXICOLOGY, 2020, 16 (04) : 484 - 486
  • [50] ACMT Position Statement: Position on the Recent Judicial Challenge of U.S. Food and Drug Administration Approval of Mifepristone
    Maryann Mazer-Amirshahi
    Andrew I. Stolbach
    Peggy Ye
    Journal of Medical Toxicology, 2023, 19 : 414 - 415
12345